A Phase 1b Study Evaluating Cobimetinib Plus Atezolizumab in Patients with Advanced BRAFv600 Wild Type Melanoma Who Have Progressed During or After Treatment with Anti-PD-1 Therapy and Atezolizumab Monotherapy in Patients with Previoulsy Untreated Advanced BRAFv600 Wild-Type Melanoma.

  • Haydon, Andrew (Primary Chief Investigator (PCI))
  • Cross, Nikki (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date7/06/18 → 7/06/23